Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature
K Ghasemi Falavarjani, QD Nguyen - Eye, 2013 - nature.com
Intravitreal injection of anti-vascular endothelial growth factor (VEGF) agents is increasingly
used for the treatment of a wide variety of retinal diseases, including age-related macular …
used for the treatment of a wide variety of retinal diseases, including age-related macular …
Retinal diseases associated with oxidative stress and the effects of a free radical scavenger (Edaravone)
T Masuda, M Shimazawa, H Hara - Oxidative medicine and …, 2017 - Wiley Online Library
Oxidative stress plays a pivotal role in developing and accelerating retinal diseases
including age‐related macular degeneration (AMD), glaucoma, diabetic retinopathy (DR) …
including age‐related macular degeneration (AMD), glaucoma, diabetic retinopathy (DR) …
Pathological angiogenesis in retinopathy engages cellular senescence and is amenable to therapeutic elimination via BCL-xL inhibition
S Crespo-Garcia, PR Tsuruda, A Dejda, RD Ryan… - Cell metabolism, 2021 - cell.com
Attenuating pathological angiogenesis in diseases characterized by neovascularization
such as diabetic retinopathy has transformed standards of care. Yet little is known about the …
such as diabetic retinopathy has transformed standards of care. Yet little is known about the …
Meta-analysis of endophthalmitis after intravitreal injection of anti–vascular endothelial growth factor agents: causative organisms and possible prevention strategies
CA Mccannel - Retina, 2011 - journals.lww.com
Purpose: To report the rates of endophthalmitis and the spectrum of causative organisms
after intravitreal injection of anti-vascular endothelial growth factor agents and possible …
after intravitreal injection of anti-vascular endothelial growth factor agents and possible …
Systemic and ocular safety of intravitreal anti-VEGF therapies for ocular neovascular disease
M Tolentino - Survey of ophthalmology, 2011 - Elsevier
The treatment of ocular neovascular diseases is being revolutionized by intravitreal
therapies targeting vascular endothelial growth factor (VEGF). Two agents are approved for …
therapies targeting vascular endothelial growth factor (VEGF). Two agents are approved for …
Updates on the current treatments for diabetic retinopathy and possibility of future oral therapy
Diabetic retinopathy (DR) is a complication of diabetes and one of the leading causes of
vision loss worldwide. Despite extensive efforts to reduce visual impairment, the prevalence …
vision loss worldwide. Despite extensive efforts to reduce visual impairment, the prevalence …
Complications of intravitreal injections
KM Sampat, SJ Garg - Current opinion in ophthalmology, 2010 - journals.lww.com
Intravitreal injections play a critical role in daily ophthalmic practice. The overall risk of
endophthalmitis and retinal detachment appears to be low and most of the commonly used …
endophthalmitis and retinal detachment appears to be low and most of the commonly used …
Meta-analysis of infectious endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents
JB Fileta, IU Scott, HW Flynn Jr - Ophthalmic Surgery, Lasers …, 2014 - journals.healio.com
BACKGROUND AND OBJECTIVE: To investigate the rate of endophthalmitis after
intravitreal injection of anti-vascular endothelial growth factor (VEGF) agents, the spectrum …
intravitreal injection of anti-vascular endothelial growth factor (VEGF) agents, the spectrum …
Systemic and ocular adverse events with intravitreal anti-VEGF therapy used in the treatment of diabetic retinopathy: a review
JA Zehden, XM Mortensen, A Reddy… - Current Diabetes Reports, 2022 - Springer
Abstract Purpose of Review Intravitreal anti-vascular endothelial growth factor (VEGF)
agents are used routinely in the management of neovascular conditions including …
agents are used routinely in the management of neovascular conditions including …
Inflammatory complications of intravitreal anti-VEGF injections
Intravitreal injection of anti-vascular endothelial growth factor (anti-VEGF) agents is a
commonly used therapy for numerous retinal diseases. The most commonly used of these …
commonly used therapy for numerous retinal diseases. The most commonly used of these …